Niki BioSolutions Inc. Common Stock (NIKI)

About NIKI

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molec…

Sector

Industrials

Industry

Industrial Machinery/Components

Employees

1

Website

www.aptorumgroup.com/

Fundamentals

1-day range

$6.9$7.61

Market cap

$27.62M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-3.54

Dividend yield

—

Beta

0.69

Avg. volume

88.4K

Niki BioSolutions Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NIKI

  Niki BioSolutions Inc. Common Stock

  $6.9

  ▼ 8.49%
  Market cap $27.62MP/E —
  $7.01$12.24
• XCH

  XCHG Limited American Depositary Share

  $3.75

  ▼ 6.84%
  Market cap $26.56MP/E —
  $3.9$49.98
• CLIR

  ClearSign Technologies Corporation Common Stock (DE)

  $4.47

  ▼ 1.54%
  Market cap $26.14MP/E —
  $3.16$112
• BEEM

  Beam Global Common Stock

  $1.47

  ▼ 5.77%
  Market cap $23.67MP/E —
  $0.9653$4.04
• UCAR

  U Power Limited Class A Ordinary Shares

  $0.6024

  ▼ 5.58%
  Market cap $31.74MP/E —
  $0.38$21.9
• PPSI

  Pioneer Power Solutions Inc. Common Stock

  $2.89

  ▼ 1.70%
  Market cap $33.51MP/E —
  $2.35$6.29
• WPRT

  Westport Fuel Systems Inc Common Shares

  $1.85

  ▼ 0.00%
  Market cap $35.14MP/E —
  $2.15$3.92

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Thursday's Pre-Market Session
  Benzinga · 8/20/2026